Therapeutic Affinity Roundtables


To jumpstart networking, Partnering for Cures featured Therapeutic Affinity Roundtables each morning during breakfast. These informal groups will gather for breakfast before each morning’s plenary session.

Each therapeutic affinity roundtable was co-hosted by representatives from industry, medical philanthropy, and/or medical research foundations who facilitated introductions and discussion.

The major categories are listed below. Please note that this list will evolve each year depending upon the needs of our registrants. Meeting attendees are invited to suggest groups and we will do our best to accommodate them.

Therapeutic Affinity Roundtables:
• Autoimmune Disease
• Cancer
• Cancer - Hematologic
• Cancer - Lung
• Cancer - Musculoskeletal
• Cancer – Pediatric
• Developmental Disorders
• Diabetes & other Metabolic Disorders
• Epilepsy & Psychiatric Disorders
• Genetic Disorders
• Global Health (Infectious & Neglected Diseases)
• Neurodegenerative Diseases & Spinal Cord Injury
• Rare Diseases
• Vision & Hearing Disorders


"This inaugural meeting is well-timed and underscores an urgent priority to bring foundations, philanthropists, and industry together. I am anticipating bold solutions can arise from well-intentioned people engaging constructively."

- Robert I. Blum, President and CEO, Cytokinetics, Inc.

Program Highlights
Confirmed Speakers
Jeffrey Kindler

Chief Executive Officer and Chairman of the Board, Pfizer
Kathy Giusti

Founder and CEO, Multiple Myeloma Research Consortium
The Hon. James Greenwood

President and CEO, Biotechnology Industry Organization
Anne Wojcicki

Co-Founder and President, 23andMe
Robert J. Beall, Ph.D.

President and CEO, Cystic Fibrosis Foundation
Debra Black

Founder and Chair, Melanoma Research Alliance
Complete List of Confirmed Speakers
Partnering for Cures Workshops and Sessions
Partnering for Cures Advisory Board

 
 
Partnering for Cures Sponsors
©2009 by Partnering for Cures  Terms Of Use  |  Privacy Statement